InvestorsHub Logo
Followers 68
Posts 12891
Boards Moderated 0
Alias Born 06/03/2015

Re: Investor2014 post# 425603

Thursday, 08/03/2023 9:14:15 AM

Thursday, August 03, 2023 9:14:15 AM

Post# of 468902

How many and under what condition might actually improve on A2-73 is tbd


With Missling stating that the trial results were better than expected and the fact that they led with Odds Ratios to highlight the super responders, provides much hope that for many patients blarcamesine will indeed be disease-modifying. Even with a slower decline, if quality of life/health is improved, with better mood, sleep, and ability to function, it'll be an amazing therapy for many.

It'll all be revealed in due time...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News